AtriCure
ATRC
100 hedge funds and large institutions have $415M invested in AtriCure in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 23 reducing their positions, and 15 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
100% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 23
14% more capital invested
Capital invested by funds: $364M → $415M (+$51.3M)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 102 → 100 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$18.6M |
| 2 |
HEC
Hudson Executive Capital
New York
|
+$7.97M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.78M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$4.37M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$3.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$12.8M |
| 2 |
Millennium Management
New York
|
-$5.12M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.53M |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$3.09M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.87M |
ATRC Hedge Fund Activity: Q3 2016 in Review
100 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2016, worth a combined $415M — up 14% from $364M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ATRC and 14 opened new positions — a net loss of 1 holder — while 23 trimmed existing stakes and 46 added.
The largest buyer was Victory Capital Management, adding an estimated $18.6M. The largest seller was Wells Fargo, cutting an estimated $12.8M.
- 100 institutional investors held AtriCure (ATRC) as of Q3 2016, down from 102 in Q2 2016.
- Funds reported $415M of AtriCure stock for Q3 2016, up 14% quarter-over-quarter.
- 14 funds opened new AtriCure positions in Q3 2016 and 15 closed out, a net change of -1 holder.
- The largest AtriCure buyer in Q3 2016 was Victory Capital Management, an estimated $18.6M added.
- The largest AtriCure seller in Q3 2016 was Wells Fargo, an estimated $12.8M sold.
Based on aggregated 13F filings for Q3 2016.